ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
1-Year Return 169.78%
This Quarter Return
+17.74%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$163M
AUM Growth
-$62.3M
Cap. Flow
-$54.6M
Cap. Flow %
-33.61%
Top 10 Hldgs %
62.79%
Holding
54
New
8
Increased
9
Reduced
9
Closed
20

Top Buys

1
TERN icon
Terns Pharmaceuticals
TERN
$7.63M
2
CBAY
Cymabay Therapeutics
CBAY
$6.36M
3
MRSN icon
Mersana Therapeutics
MRSN
$5.57M
4
RCKT icon
Rocket Pharmaceuticals
RCKT
$5.09M
5
KROS icon
Keros Therapeutics
KROS
$3.84M

Top Sells

1
APLS icon
Apellis Pharmaceuticals
APLS
$17.4M
2
RLMD icon
Relmada Therapeutics
RLMD
$13.5M
3
XENE icon
Xenon Pharmaceuticals
XENE
$9.84M
4
BLSA
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$8.45M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$7.32M

Sector Composition

1 Healthcare 99.99%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IOVA icon
26
Iovance Biotherapeutics
IOVA
$901M
$982K 0.6%
153,639
– –
MLTX icon
27
MoonLake Immunotherapeutics
MLTX
$3.77B
$982K 0.6%
+93,500
New +$982K
PYXS icon
28
Pyxis Oncology
PYXS
$118M
$897K 0.55%
669,158
– –
RZLT icon
29
Rezolute
RZLT
$696M
$869K 0.54%
420,000
+855
+0.2% +$1.77K
HZNP
30
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$683K 0.42%
6,000
+2,000
+50% +$228K
PRTA icon
31
Prothena Corp
PRTA
$460M
$560K 0.34%
+9,300
New +$560K
ELVN icon
32
Enliven Therapeutics
ELVN
$1.19B
$182K 0.11%
+11,126
New +$182K
KNTE
33
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$30.5K 0.02%
5,000
– –
NUVB.WS icon
34
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$64.6M
$13.1K 0.01%
90,832
– –
ALLK
35
DELISTED
Allakos
ALLK
– –
-192,500
Closed -$1.18M
ALT icon
36
Altimmune
ALT
$334M
– –
-125,000
Closed -$1.6M
BMEA icon
37
Biomea Fusion
BMEA
$114M
– –
-1,000
Closed -$10K
ESPR icon
38
Esperion Therapeutics
ESPR
$540M
– –
-30,000
Closed -$201K
FOLD icon
39
Amicus Therapeutics
FOLD
$2.46B
– –
-290,000
Closed -$3.03M
GOSS icon
40
Gossamer Bio
GOSS
$668M
– –
-284,500
Closed -$3.41M
IDYA icon
41
IDEAYA Biosciences
IDYA
$2.38B
– –
-10,000
Closed -$149K
MIST icon
42
Milestone Pharmaceuticals
MIST
$153M
– –
-597,026
Closed -$5.49M
MRUS icon
43
Merus
MRUS
$5.1B
– –
-59,000
Closed -$1.18M
RLMD icon
44
Relmada Therapeutics
RLMD
$54.8M
– –
-365,618
Closed -$13.5M
SWTX
45
DELISTED
SpringWorks Therapeutics
SWTX
– –
-5,000
Closed -$143K
TRVI icon
46
Trevi Therapeutics
TRVI
$854M
– –
-36,302
Closed -$56K
XENE icon
47
Xenon Pharmaceuticals
XENE
$3.02B
– –
-272,500
Closed -$9.84M
ZNTL icon
48
Zentalis Pharmaceuticals
ZNTL
$126M
– –
-5,000
Closed -$108K
NGM
49
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
– –
-7,500
Closed -$98K
IMGN
50
DELISTED
Immunogen Inc
IMGN
– –
-140,000
Closed -$669K
1
2
3